BERGER FRANKLIN M
SEC CIK 1273885 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Dir | 536.1K | — | $1.24M | 7 | 2022-11-11 | 2026-06-18 |
Most active insiders at AVIR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Murphy Polly A. | Dir | $25.4K | — |
| 2 | Adams Jerome M. | Dir | — | — |
| 3 | Hammond Janet MJ | Chief Development Off | — | — |
| 4 | Vavricka John | Chief Commercial Off | — | — |
| 5 | Lucidi Bruno | Dir | — | — |
| 6 | Horga Maria Arantxa | Chief Medical Off | — | — |
| 7 | Foster Wayne | EVP, CAO | — | — |
| 8 | Polsky Bruce | Dir | — | — |
| 9 | DUNCAN BARBARA GAYLE | Dir | — | — |
| 10 | Corcoran Andrea | See Remarks | — | — |
| 12 | BERGER FRANKLIN M | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:00 | 2026-06-18 | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | M - OptEx | $0.00 | +29.6K | 536.1K | +6% | $0 |
| D | 2025-06-24 | 2025-06-20 | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | M - OptEx | $0.00 | +29.6K | 506.5K | +6% | $0 |
| MA | 2025-01-17 | 2025-01-15+ | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | P - Purchase | $3.26 | +25.0K | 476.9K | +6% | +$81.5K |
| M | 2025-01-17 | 2025-01-15+ | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | P - Purchase | $3.26 | -25.0K | 476.9K | -5% | -$81.5K |
| 2024-12-12 | 2024-12-10 | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | S - Sale | $2.85 | -359.6K | 451.9K | -44% | -$1.02M | |
| D | 2024-06-18 | 2024-06-16 | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | M - OptEx | $0.00 | +33.1K | 811.5K | +4% | $0 |
| M | 2022-11-15 | 2022-11-11+ | AVIR | Atea Pharmaceuticals, Inc. | BERGER FRANKLIN M | Dir | S - Sale | $5.15 | -41.7K | 778.4K | -5% | -$214.7K |
Purchase Sale Sale after option exercise All abbreviations